MedTech Innovator Recognizes cellvie as 2020 Value Award Winner at the MedTech Strategist Virtual Summit
/
DateNov 18 2020
Based in Germany, cellvie is developing a device-enabled mitochondria transplantation therapy for heart disease. As winners of the Value Award competition, cellvie will receive a $25,000 non-dilutive cash prize and a profile in an upcoming issue of the MedTech Strategist.
Read More →

















